Personalized Medicine – Products

LungExpress Dx™ is a proprietary gene expression-based test to improve upon staging for identifying those patients with early-stage NSCLC.

New tools for understanding biological pathways and accelerating drug development for personalized medicine.

TriLink BioTechnologies (TriLink), a leading provider of custom nucleic acid-based products, today announced the launch of an innovative Hot Start solution for the PCR amplification of problematic GC-rich sequences, CleanAmp™ 7-deaza-dGTP.

Australia, India, New Zealand, Singapore and Taiwan recognize the 3500 Dx series Genetic Analyzer for in vitro diagnostic use.

Nobel Laureate, Seamus Heaney, opens McClay library following £10 million personal donation from Almac founder, Sir Allen McClay.

The software provides deep insights into the underlying biology of cancer from the analysis of digital pathology and non-invasive medical images.

XCEL™ array is a high density transcriptome based microarray based on the industry standard Affymetrix GeneChip® platform.

New Core Panel designed to help researchers study genetic predispositions for differential drug response and adverse events.

New generation of the MassARRAY system now addresses the needs of lower throughput laboratories.

Now, 115 of the most common cancer genes are available for HybSelectâ, febit’s automated technology for sequence capture enabling targeted NGS studies.